KALY 2019 $20 Million CBD Extraction Target Receives Support From New York Trend

Date : 06/17/2019 @ 4:45PM
Source :InvestorsHub NewsWire
Stock : Puration Inc. (PC) (PURA)
Quote : 0.0468  0.0 (0.00%) @ 12:31PM

KALY 2019 $20 Million CBD Extraction Target Receives Support From New York Trend

KALY 2019 $20 Million CBD Extraction Target Receives Support From New York Trend

Extraction Business Adds to KALY Pharma Business and PURA and USMJ Partnerships
 

Dallas, TX -- June 17, 2019 -- InvestorsHub NewsWire -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) plans to expand its CBD extraction business to $20 million in 2019 sales.  KALY recently announced a contract with a New York State Licensed Hemp Cultivation Operation anticipated to generate an estimated $5 million in revenue for KALY.  Today, based on an NBC News Report, KALY’s hemp derived CBD extraction business seems more than ever to be on point in the State of New York.  The report highlights a major farming movement in New York toward hemp cultivation.  Management is remaining open to the potential of raising its 2019 $20 million CBD extraction target.

See KALY’s full plan to expand its extraction business to $20 million in sales:

Kali-Extracts Mobile Cannabis Extraction Capacity

KALY Pharma Business and PURA and USMJ Partnerships

KALY is primarily a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from a proprietary cannabinoid product platform in a broad range of disease areas. In the fourth quarter of last year, 2018, KALY acquired NCM Biotech (NCMB). In NCMB’s four years of operations, the company has established a leading position in the development of plant-derived cannabinoid therapeutics through a proven drug discovery and patented development process.  The resulting intellectual property portfolio and the established regulatory and manufacturing expertise have created a significant opportunity. KALY has a deep pipeline of cannabinoid product candidates including four distinct compounds. KALY has completed the first stage of clinical development and testing for a Chronic Obstructive Pulmonary Disease (COPD) therapy and is currently conducting phase one development and trials for compounds targeting Cancer Pain Management, Type 2 Diabetes and Epilepsy.

KALY is not relying on its biopharmaceutical development strategy alone to insure the company’s long-term success.  With the popularity of cannabis extracts for infusion into various consumer products, KALY’s patented extraction process offers arguably the highest quality extract to the infusion market.  Drawing on KALY’s patented cannabis extraction expertise, in addition to winning the $5 million extraction contract mentioned above, KALY has partnered with Puration, Inc. (PURA) to lend its extraction expertise in the production of EVERx CBD Sports Water, the leading CBD infused beverage for the sports nutrition market.  KALY has also introduced its own CBD confections line, Hemp4mula with CBD infused gum already on the market and gummies on the way.  Hemp4mula is available on the Ecommerce site USMJ.com hosted by North American Cannabis Holdings, Inc. (aka USMJ). KALY’s non-pharmaceutical extraction revenue strategy offers a business line that can stand alone, and at the same time provide KALY with the long-term staying power to bring its cannabis extract biopharmaceutical products to market.  


To learn more about the company visit https://www.kali-extracts.com/

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.

CONTACT:
Frederick Ferri
ir@kali-extracts.com

(214) 210-0459

 

Puration Inc. (PC) (USOTC:PURA)
Historical Stock Chart

1 Year : From Sep 2018 to Sep 2019

Click Here for more Puration Inc. (PC) Charts.

Puration Inc. (PC) (USOTC:PURA)
Intraday Stock Chart

Today : Tuesday 17 September 2019

Click Here for more Puration Inc. (PC) Charts.

Latest PURA Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.